8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension
Clinical trial NCT01570686 · COMPLETED
Trial details
- NCT number
- NCT01570686
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-11-01
- Enrollment
- 589
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.